Astec Lifesciences Closes Trading Window for Insider Trading

Astec Lifesciences Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. All officers and designated employees, including directors and auditors, are prohibited from trading in the company's equity shares during this period to prevent potential insider trading.